What Is the Role of Adjuvant Therapy After Liver Transplantation for Hepatocellular Carcinoma?

被引：19

作者：

Duvoux, Christophe ^{[1
]}

Kiuchi, Tetsuya ^{[2
]}

Pestalozzi, Bernhard ^{[3
]}

Busuttil, Ronald ^{[4
]}

Miksad, Rebecca ^{[5
]}

机构：

[1] Paris Est Creteil Univ, Henri Mondor Hosp, AP HP, Liver Transplant Unit, Creteil, France

[2] Nagoya Univ Med, Nagoya Univ Hosp, Dept Surg, Div Transplantat Surg, Nagoya, Aichi, Japan

[3] Univ Zurich Hosp, Clin & Polyclin Oncol, CH-8091 Zurich, Switzerland

[4] Calif State Univ Los Angeles, Div Liver & Pancreas Transplantat, Dept Surg, Los Angeles, CA 90032 USA

[5] Beth Israel Deaconess Med Ctr, Dept Med, Div Oncol, Boston, MA 02215 USA

来源：

LIVER TRANSPLANTATION | 2011年 / 17卷

关键词：

SELECTION CRITERIA; END-POINTS; SORAFENIB; CHEMOTHERAPY; RECURRENCE; CIRRHOSIS; MULTICENTER; REGISTRY; IMPACT; EXPERIENCE;

D O I：

10.1002/lt.22367

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S147 / S158

页数：12

共 46 条

[1] Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle [J].

Bhoori, Sherrie ;

Toffanin, Sara ;

Sposito, Carlo ;

Germini, Alessandro ;

Pellegrinelli, Alessandro ;

Lampis, Andrea ;

Mazzaferro, Vincenzo .

JOURNAL OF HEPATOLOGY, 2010, 52 (05) :771-775

[2] LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].

BISMUTH, H ;

CHICHE, L ;

ADAM, R ;

CASTAING, D ;

DIAMOND, T ;

DENNISON, A .

ANNALS OF SURGERY, 1993, 218 (02) :145-151

[3] Liver transplantation for hepatocellular carcinoma [J].

Bismuth, H ;

Majno, PE ;

Adam, R .

SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322

[4] Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies [J].

Chan, Edie Y. ;

Larson, Anne M. ;

Fix, Oren K. ;

Yeh, Matthew M. ;

Levy, Adam E. ;

Bakthavatsalam, Ramasamy ;

Halldorson, Jeffrey B. ;

Reyes, Jorge D. ;

Perkins, James D. .

LIVER TRANSPLANTATION, 2008, 14 (07) :956-965

[5]

Chen Gui-Hua, 2004, Zhonghua Wai Ke Za Zhi, V42, P1040

[6]

CHERQUI D, 1994, CANCER, V73, P2721, DOI 10.1002/1097-0142(19940601)73:11<2721::AID-CNCR2820731112>3.0.CO

[7]

2-K

[8] Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma:: A multicenter study of 412 patients [J].

Decaens, Thomas ;

Roudot-Thoraval, Francoise ;

Bresson-Hadni, Solange ;

Meyer, Carole ;

Gugenheim, Jean ;

Durand, Francois ;

Bernard, Pierre-Henri ;

Boillot, Olivier ;

Compagnon, Philippe ;

Calmus, Yvon ;

Hardwigsen, Lean ;

Ducerf, Christian ;

Pageaux, Georges Philippe ;

Dharancy, Sebastien ;

Chazouilleres, Olivier ;

Cherqui, Daniel ;

Duvoux, Christophe .

WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (45) :7319-7325

[9]

Dharancy S, 2008, LIVER TRANSPLANT, V14, pS216

[10] Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis:: Results of a multicenter study [J].

Figueras, J ;

Ibañez, L ;

Ramos, E ;

Jaurrieta, E ;

Ortiz-de-Urbina, J ;

Pardo, F ;

Mir, J ;

Loinaz, C ;

Herrera, L ;

López-Cillero, P ;

Santoyo, J .

LIVER TRANSPLANTATION, 2001, 7 (10) :877-883

← 1 2 3 4 5 →